Year: 2020

news_6

BeiGene Announces the Approval of XGEVA® (Denosumab) in China for the Prevention of Skeletal-Related Events in Patients With Bone Metastases From Solid Tumors and in Patients With Multiple Myeloma

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$BGNE #BGNE--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

news_6

Insights on the Semiconductors Market In Vietnam 2020-2024: COVID-19 Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 – Technavio

LONDON--(BUSINESS WIRE)--#SemiconductorsMarketinVietnam--The semiconductors market in Vietnam is expected to grow by USD 6.16 bn, progressing at a CAGR of almost...

news_6

AM Best Revises Issuer Credit Rating Outlook to Positive for China Reinsurance (Group) Corporation and Its Subsidiaries; Affirms Credit Ratings of China Reinsurance (Hong Kong) Company Limited